Appropriate invasive and conservative treatment strategies for patients with ST elevation myocardial infarction

Pedro L Sánchez1, Francisco Fernández-Avilés

  • 1Coronary Care Unit, Instituto de Ciencias del Corazón ICICOR, Hospital Clínico Universitario, Valladolid, Spain.

Insights

Rapid reperfusion is key for ST elevation myocardial infarction (STEMI). Primary PCI is ideal, but thrombolysis is effective when PCI is delayed or unavailable, improving patient outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Interventional Cardiology

Background:

  • ST elevation myocardial infarction (STEMI) requires rapid reperfusion of the occluded coronary artery.
  • Geographical and logistical barriers significantly impact treatment accessibility and timeliness.

Purpose of the Study:

  • To review evidence on optimal reperfusion strategies for STEMI patients.
  • To consider geographical and logistical factors influencing treatment choices.

Main Methods:

  • Review of current evidence and guidelines on STEMI reperfusion.
  • Analysis of the efficacy and limitations of primary percutaneous coronary intervention (PCI) versus thrombolysis.

Main Results:

  • Primary PCI is the gold standard but limited to 29% of STEMI patients globally due to logistical barriers.
  • Early thrombolysis (within 1-2 hours) is as effective as primary PCI, significantly reducing mortality.
  • Guidelines recommend primary PCI within 90 minutes of first medical contact or thrombolysis within 30 minutes of hospital presentation.

Conclusions:

  • Reperfusion strategy selection depends on patient transportation and hospital capabilities.
  • Hospitals with PCI facilities should prioritize primary PCI.
  • Community hospitals without PCI should consider fibrinolysis or transfer for PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...